For how we live.
Every article we have published on Global Burden Of Disease, newest first.
The Global Burden of Disease estimates for anxiety disorders separate two things that public debate keeps merging: how many people have it, and how likely a given person is to. Diagnosis is a third question again.
New GBD analysis across 21 countries finds one group whose burden fell — children — while incidence rose 92% overall and the sex pattern inverted.
A Global Burden of Disease comparison puts the 2023 US maternal mortality rate at 33.8 per 100,000 live births, alongside cardio-kidney-metabolic risk burdens several times those of other high-income countries.
A single-author analysis of Global Burden of Disease estimates finds the region's neurodevelopmental picture split in two — and argues the flat autism curve reflects diagnostic capacity, not risk.
Two November burden analyses put diabetes diagnosed before 40 on an upward path to 2050. In the Americas, Central Latin America carried the highest rates and men carried more of the burden than women.
A meta-regression across 28 countries put pooled prevalence near 4-5% and standardised mortality ratios between 1.8 and 4.7, in a condition the Global Burden of Disease study does not count.
A new GBD analysis puts sepsis-related deaths at 21.4 million, roughly double the 11.0 million estimated for 2017 — a change driven partly by COVID-19 and partly by a different method.
Age-standardised disability-adjusted life-years fell 12.6% since 2010, but the raw total rose 6.1% to 2.80 billion. Anxiety, depression and diabetes rose fastest even after adjusting for ageing.